Understanding the influence of the microbiome on childhood infections
Expert Rev Anti Infect Ther. 2024 Apr 12:1-17. doi: 10.1080/14787210.2024.2340664. Online ahead of print.ABSTRACTINTRODUCTION: The microbiome is known to have a substantial impact on human health and disease. However, the impacts of the microbiome on immune system development, susceptibility to infectious diseases, and vaccine-elicited immune responses are emerging areas of interest.AREAS COVERED: In this review, we provide an overview of development of the microbiome during childhood. We highlight available data suggesting that the microbiome is critical to maturation of the immune system and modifies susceptibility to a ...
Source: Expert Review of Anti-Infective Therapy - April 12, 2024 Category: Infectious Diseases Authors: Sarah M Heston Jillian H Hurst Matthew S Kelly Source Type: research

Response to: 'letter to the editor: "A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials "'
Expert Rev Anti Infect Ther. 2024 Apr 5:1-3. doi: 10.1080/14787210.2024.2337824. Online ahead of print.NO ABSTRACTPMID:38576383 | DOI:10.1080/14787210.2024.2337824 (Source: Expert Review of Anti-Infective Therapy)
Source: Expert Review of Anti-Infective Therapy - April 5, 2024 Category: Infectious Diseases Authors: Eric Kofi Ngyedu Joseph Elikem Efui Acolatse George Akafity Robert Incoom Audu Rauf R Andrew Seaton Jacqueline Sneddon Elaine Cameron Margaret Watson Marta Wanat Brian Godman Amanj Kurdi Source Type: research

The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants
CONCLUSION: The use of novel oral antiviral including NMV-r or MOV can be associated with a lower risk of all-cause hospitalization, or death in non-hospitalized high-risk patients with COVID-19 during Omicron XBB wave.PMID:38568820 | DOI:10.1080/14787210.2024.2339398 (Source: Expert Review of Anti-Infective Therapy)
Source: Expert Review of Anti-Infective Therapy - April 3, 2024 Category: Infectious Diseases Authors: Chi-Kuei Hsu Wan-Hsuan Hsu Bo-Wen Shiau Ya-Wen Tsai Jheng-Yan Wu Ting-Hui Liu Po-Yu Huang Min-Hsiang Chuang Chih-Cheng Lai Source Type: research

Non-cancerous complications in HTLV-1 carriers
Expert Rev Anti Infect Ther. 2024 Apr 1:1-10. doi: 10.1080/14787210.2024.2336547. Online ahead of print.ABSTRACTINTRODUCTION: Human T-cell leukemia virus type 1 (HTLV-1) carriers may develop adult T-cell leukemia (ATL), or HTLV-1-associated myelopathy (HAM)/tropical spastic paraparesis (TSP). The evidence is limited regarding other diseases potentially associated with HTLV-1, such as HTLV-1-associated autoimmune diseases.AREA COVERED: We summarized the available information on complications associated with HTLV-1 infection.EXPERT OPINION: Previous studies showed that HTLV-1 carriers have an increased incidence of collagen ...
Source: Expert Review of Anti-Infective Therapy - March 27, 2024 Category: Infectious Diseases Authors: Akihiro Ohmoto Shigeo Fuji Source Type: research